Healthcare Realty Trust Incorporated Common Stock (HR)
Slow GrowerFairStock Score: 53/100 — MIXED
Key Financials
| Current Price | $20.29 |
| Market Cap | $6.4B |
| P/E Ratio | -34.98 |
| ROE | -4.23% |
| Dividend Yield | 4.89% |
| Sector | Real Estate |
Strengths
- Generates $144 million in annual free cash flow (2.3% yield on market cap)
- Strong Piotroski F-Score of 7/9 indicating robust financial health across profitability, leverage, and efficiency metrics
- Attractive 4.7% dividend yield providing steady income returns
Concerns
- Revenue declining at 11.2% year-over-year signals potential demand weakness or market share loss
- Altman Z-Score of 0.9 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
Healthcare Realty Trust Incorporated Common Stock is a small-cap real estate company valued at $6.4 billion. The business generates $1.2 billion in annual revenue with a 1.2% net margin and $144 million in free cash flow. From a quality standpoint, Healthcare shows solid Piotroski F-Score of 7/9 and distressed Altman Z-Score of 0.9 warrants caution. On valuation, the stock is 0.7% FCF yield. Growth dynamics show revenue growing at -11.2% and profit growth of 113.5%. The 4.7% dividend yield adds an income component for patient holders. Our composite FairStock Score of 53/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $144 million in annual free cash flow (2.3% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the real estate space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer